Effects of Rikkunshito on the Pharmacokinetics of Digoxin

Effects of Rikkunshito on the Pharmacokinetics of Digoxin - Rikkunshito Effects on Digoxin Pharmacokinetics

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016656

Enrollment

Registered

2015-02-27

Start date

2015-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Male Volunteer

Interventions

Multiple dose of Rikkunshito 2.5 g Single dose of Digoxin 0.25 mg

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy male volunteer

Exclusion criteria

Exclusion criteria: Volunteer with history of psychiatric disorder and alcohol poisoning

Design outcomes

Primary

Measure	Time frame
Digoxin pharmacokinetics	—

Secondary

Measure	Time frame
Safety	—

Countries

Japan

Contacts

Public ContactJunichi Hasegawa

Tottori University Faculty of Medicine Pharmacotherapeutics

hasegawa@med.tottori-u.ac.jp0859-38-6171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026